Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
Oncology·MeSH: Lymphoma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Surovatamig | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV?
BioSniper tracks 1 drug in development for Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV across 1 company.
How many clinical trials target Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV?
There are 1 clinical trial targeting Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV tracked by BioSniper.
Deep-dive into Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis